Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2017-08-01
2022-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Long-term vary between 50-60%. This study examines whether urodynamics can be used as a predictor for successful SNM therapy
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Time of Effect Onset in Treating Overactive Bladder or Non Obstructive Urinary Retention by Sacral Neuromodulation
NCT02040519
Sacral Neuromodulation and Pudendal Somatic Afferents
NCT03614754
Evaluation of Autonomic Nervous System Changes in Response to Stimulation by Sacral Neuromodulation
NCT06434831
Ambulatory Urodynamic Evaluation of Sacral Neuromodulation for Non-Obstructive Urinary Retention
NCT00970242
Screening Method in Sacral Neuromodulation
NCT01130415
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Successes
Patients with \>50% improvement during test procedure of sacral neuromodulation.
urodynamics
Bladder filling and pressure is measured by the insertion of probes within the bladder, urethra and anorectum.
Failures
Patients with \<50% improvement during test procedure of sacral neuromodulation.
urodynamics
Bladder filling and pressure is measured by the insertion of probes within the bladder, urethra and anorectum.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
urodynamics
Bladder filling and pressure is measured by the insertion of probes within the bladder, urethra and anorectum.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Non-obstructive urinary retention
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universiteit Antwerpen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Donald Vaganée
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stefan De Wachter, MD PhD FEBU
Role: STUDY_DIRECTOR
University Hospital, Antwerp
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of antwerp
Antwerp, Edegem, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Stefan De Wachter, MD PhD FEBU
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17/30334
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.